Showing all 4 results
Amiodarone Tablet
FreeProduct Composition & Available Strengths
We manufacture Amiodarone in standard, internationally recognized strengths to allow for the intensive loading phase and lower maintenance doses required in cardiology.
Active Ingredient Standard Strengths Primary Clinical Target Amiodarone HCl BP / IP / USP 100 mg Low-Dose Maintenance: For fine-tuned long-term rhythm control and geriatric titration. Amiodarone HCl BP / IP / USP 200 mg Standard Therapy: Used for initial institutional oral loading phases and standard daily maintenance. Amlodipine & Enalapril Maleate Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets to protect the Enalapril Maleate from moisture-induced degradation and to ensure the physical integrity of the combination.
Active Ingredient Strength (Standard) Therapeutic Role Amlodipine (as Besylate) BP/USP 5 mg / 10 mg Calcium Channel Blocker (CCB) Enalapril Maleate BP/USP 5 mg / 10 mg / 20 mg ACE Inhibitor Excipients Q.S. Sodium Stearyl Fumarate / Lactose Lubricant & Stabilizer Amlodipine Besylate & Losartan Potassium Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. The formulation is optimized for 24-hour efficacy, allowing for convenient once-daily dosing.
Active Ingredient Strength (Standard) Therapeutic Role Amlodipine Besylate BP/USP 5 mg Calcium Channel Blocker (CCB) Losartan Potassium BP/USP 50 mg Angiotensin Receptor Blocker (ARB) Excipients Q.S. Microcrystalline Cellulose / Starch Stabilizing Core Matrix Metoprolol Tablet
FreeCore Product Catalog:
Active Ingredient Monograph Standard Strengths Dosage Format Primary Clinical Target Metoprolol Tartrate IP/BP/USP 25 mg Immediate-Release Solid Tablet Acute Titration: For fine-tuned early adjustment in arrhythmias and mild hypertension. Metoprolol Tartrate IP/BP/USP 50 mg Immediate-Release Solid Tablet Standard Twice-Daily Blockade: Routine maintenance for Angina Pectoris and post-Myocardial Infarction stabilization. Metoprolol Tartrate IP/BP/USP 100 mg Immediate-Release Solid Tablet High-Threshold Control: For refractory tachyarrhythmias and intensive post-MI clinical management.
